Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Update Il y a 4 ans
Reference: NCT01467323

Woman and Man

Extract

This trial is conducted in Europe. The aim of this trial is to evaluate the efficacy and safety of biphasic insulin aspart 30 in subjects with type 1 or type 2 diabetes.


Inclusion criteria

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2


Links